Hydroxychloroquine prescribed to 300,000 more patients than usual after Trump endorsement

Prescriptions for two anti-malaria drugs to treat the novel coronavirus soared by hundreds of thousands in March, a new study suggests. Typically, only about 380,000 people are prescribed hydroxychloroquine and its analog chloroquine to treat malaria, lupus and rheumatoid arthritis. However, in March, President Donald Trump hailed the drug, which also is used to treat arthritis … Read more Hydroxychloroquine prescribed to 300,000 more patients than usual after Trump endorsement

Another 35,000 cancer patients could die in a year due to Covid delays

Another 35,000 cancer patients could die in a year due to Covid delays as experts warn of an ‘explosion of ill health’ Up to 35,000 more cancer patients could die in a year due to the pandemic  Appointments and treatments have been delayed amid the coronavirus crisis The UK could see 18,000 more cancer deaths … Read more Another 35,000 cancer patients could die in a year due to Covid delays

50% fewer COVID-19 patients died when treated with hydroxychloroquine

After repeated failures in previous research, a new study suggests hydroxychloroquine can improve survival odds for some coronavirus patients.  Hospitalized coronavirus patients given hydroxychloroquine were 50 percent less likely to die of the brutal infection than those who did not receive the drug in a Henry Ford Health System study of 2,541 people.  It comes … Read more 50% fewer COVID-19 patients died when treated with hydroxychloroquine

One in 10 Covid patients who lose their taste and smell may never get it back

Up to 10% of Covid-19 patients who lose their sense of taste or smell may not get it back within a month, study finds A change in smell or taste is recognised by health officials as sign of Covid-19 Study of Covid-19 patients showed half had fully regained their smell and taste But 10% said … Read more One in 10 Covid patients who lose their taste and smell may never get it back

50% fewer COVID-19 patients died when treated with hydroxychloroquine

After repeated failures in previous research, a new study suggests hydroxychloroquine can improve survival odds for some coronavirus patients.  Hospitalized coronavirus patients given hydroxychloroquine were 50 percent less likely to die of the brutal infection than those who did not receive the drug in a Henry Ford Health System study of 2,541 people.  It comes … Read more 50% fewer COVID-19 patients died when treated with hydroxychloroquine

Where NYC COVID-19 patients are treated may determine death risks

The odds that a New York City resident admitted to a hospital for COVID-19 will die vary wildly, depending on what hospital they go to, a New York Times investigation has revealed.  Hospital data obtained by the Times shows that mortality rates for COVID-19 patients are as low as 11 percent at private Manhattan hospitals, … Read more Where NYC COVID-19 patients are treated may determine death risks

Coronavirus patients are eight times more likely to suffer a stroke compared to flu patients

Coronavirus patients are EIGHT TIMES more likely to suffer a stroke than flu patients, study finds Of more than 1,900 patients either in the ER or hospitalized with coronavirus, 1.6% suffered an ischemic stroke One-third of COVID-19 patients who had strokes were severe cases who were on mechanical ventilation About 32% of coronavirus patients who … Read more Coronavirus patients are eight times more likely to suffer a stroke compared to flu patients

Coronavirus vaccine triggered antibody levels up to 3 times greater than those in recovered patients

Experimental coronavirus vaccine from Pfizer triggered levels of antibodies up to THREE TIMES greater than those seen in recovered patients, early data shows Researchers randomly gave 45 healthy volunteers either a low dose, a medium dose or a high dose of a coronavirus vaccine, or a placebo Those who received the vaccine were given two shots, except … Read more Coronavirus vaccine triggered antibody levels up to 3 times greater than those in recovered patients

NHS heart, stomach and arthritis patients face treatment delays for up to TWO YEARS

Britons could be waiting up to two years for NHS treatment due to Covid-19 infection control rules. Almost half of heart, stomach and other specialists will be working at reduced levels for the next 12 months, according to the Royal College of Physicians. Non-emergency NHS surgery was paused for three months in mid-March to prepare … Read more NHS heart, stomach and arthritis patients face treatment delays for up to TWO YEARS

Fears for UK coronavirus patients as the US buys almost the ENTIRE world stock of remdesivir

The US has bought almost the entire global supply of one of only two drugs proven to be effective against coronavirus.         The drug, made by American pharmaceutical firm Gilead, was initially developed as a failed Ebola treatment but studies have now shown it speeds up recovery from coronavirus. However, patients in the UK and Europe … Read more Fears for UK coronavirus patients as the US buys almost the ENTIRE world stock of remdesivir